Vanessa Carle, Secretary at Lexaria Bioscience Corp. (LEXX), sold 2,567 shares at $4.00 ($10K) on 2024-07-31, disclosed to the SEC on 2024-08-01.
Open-market sale of $10k LEXX by Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.